ISSN 2149-2263 | E-ISSN 2149-2271
pdf
Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: A cross-sectional study in the Turkish population [Anatol J Cardiol]
Anatol J Cardiol. 2017; 17(1): 66-72 | DOI: 10.14744/AnatolJCardiol.2016.6679

Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: A cross-sectional study in the Turkish population

Ayşe Esra Koku Aksu1, Zeynep Nurhan Saraçoğlu2, Selma Metintaş3, İlham Sabuncu2, Yıldız Çetin4
1Department of Dermatology, İstanbul Training and Research Hospital, İstanbul-Turkey
2Departments of Dermatology, Eskişehir Osmangazi University, Eskisehir-Turkey
3Public Health, Eskişehir Osmangazi University, Eskisehir-Turkey
4Department of Dermatology, Kent Hospital, Kütahya-Turkey

Objective: Psoriasis is associated with an increased frequency of cardiovascular risk factors. Metabolic syndrome (MS) and the Framingham risk score (FRS) are two different algorithms for evaluating cardiovascular risk. They include different features: waist circumference measurement is included in the MS criteria, whereas smoking, age, and gender are questioned in FRS. This study aimed to evaluate the frequency of MS and FRS in psoriasis patients compared with a control group and investigate the differences between MS and FRS.
Methods: This was a cross-sectional study involving 300 psoriasis patients and 177 controls. MS, FRS, and disease severity were evaluated.
Results: The frequency of MS was higher in females with psoriasis than in those in the control group (p=0.019). Females in the psoriasis group were more obese than those in the control group (p=0.036). FRS significantly differed between the patients and controls of age >60 years (p=0.006). The risk of hypertension in current and past smokers was higher in the psoriasis patients (OR=2.07 and 2.32–2.48, respectively) than in the control group. There was no statistically significant relationship among MS, FRS, and psoriasis severity (p>0.05).
Conclusion: The results of this study support the evaluation of cardiovascular risk assessment in female psoriasis patients with MS and in male and elderly psoriasis patients with FRS. (Anatol J Cardiol 2017; 17: 66-72)

Keywords: Framingham risk score, metabolic syndrome, psoriasis

Ayşe Esra Koku Aksu, Zeynep Nurhan Saraçoğlu, Selma Metintaş, İlham Sabuncu, Yıldız Çetin. Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: A cross-sectional study in the Turkish population. Anatol J Cardiol. 2017; 17(1): 66-72

Corresponding Author: Ayşe Esra Koku Aksu, Türkiye
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.